- Report
- July 2023
- 93 Pages
Global
From €3500EUR$3,949USD£3,056GBP
- Report
- June 2023
- 126 Pages
Global
From €3500EUR$3,949USD£3,056GBP
- Report
- June 2023
- 86 Pages
Global
From €3500EUR$3,949USD£3,056GBP
- Report
- June 2023
- 125 Pages
Global
From €3500EUR$3,949USD£3,056GBP
- Report
- July 2024
- 158 Pages
Global
From €4035EUR$4,250USD£3,403GBP
- Report
- October 2023
- 80 Pages
Vietnam
From €1424EUR$1,500USD£1,201GBP
- Report
- October 2023
- 80 Pages
Russia
From €1424EUR$1,500USD£1,201GBP
- Report
- October 2023
- 80 Pages
Poland
From €1424EUR$1,500USD£1,201GBP
- Report
- October 2023
- 80 Pages
Japan
From €1424EUR$1,500USD£1,201GBP
- Report
- October 2023
- 80 Pages
Ireland
From €1424EUR$1,500USD£1,201GBP
- Report
- October 2023
- 80 Pages
Brazil
From €1424EUR$1,500USD£1,201GBP
- Report
- October 2023
- 80 Pages
Argentina
From €1424EUR$1,500USD£1,201GBP
- Report
- March 2024
- 132 Pages
Global
From €902EUR$950USD£761GBP

The Injectable Delivery System market is composed of a variety of products and services related to the delivery of infusions and injectables. These products and services include syringes, needles, auto-injectors, infusion pumps, and other related accessories. Injectable delivery systems are used to deliver medications, nutrients, and other substances directly into the body. They are used in a variety of medical settings, including hospitals, clinics, and home care.
Injectable delivery systems are designed to provide accurate and safe delivery of medications and other substances. They are designed to reduce the risk of infection and other complications associated with the administration of infusions and injectables. In addition, they are designed to reduce the amount of time required for administration and to improve patient comfort.
Companies in the Injectable Delivery System market include Becton Dickinson, Baxter, Hospira, Smiths Medical, and Terumo. Show Less Read more